Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Greta Alì

Showing results (81-90 of 99) with videos related to

Pageof 10
Sort By:
Oncology Reports|September 3, 2009
Epidermal growth factor receptor and K-RAS mutations in 411 lung adenocarcinoma: a population-based prospective studyLaura Boldrini, Greta Alì, Silvia Gisfredi, et al.
Endocrine|September 12, 2023
SARS-CoV-2 spread to endocrine organs is associated with obesity: an autopsy study of COVID-19 casesAnello Marcello Poma, Alessio Basolo, Greta Alì, et al.
Cancers|April 13, 2024
Early-Stage Non-Small Cell Lung Cancer: Prevalence of Actionable Alterations in a Monocentric Consecutive CohortRossella Bruno, Anello Marcello Poma, Martina Panozzi, et al.
Archives of Pathology & Laboratory Medicine|June 3, 2014
ALK rearrangement in a large series of consecutive non-small cell lung cancers: comparison between a new immunohistochemical approach and fluorescence in situ hybridization for the screening of patients eligible for crizotinib treatmentGreta Alì, Agnese Proietti, Serena Pelliccioni, et al.
European Journal of Radiology|August 20, 2024
Large cell carcinoma of the lung: LDCT features and survival in screen-detected casesMario Mascalchi, Donella Puliti, Edoardo Cavigli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2017
Homeobox B9 Mediates Resistance to Anti-VEGF Therapy in Colorectal Cancer PatientsCarmine Carbone, Geny Piro, Francesca Simionato, et al.
The Journal of Clinical Endocrinology and Metabolism|December 15, 2010
Novel pyrazolopyrimidine derivatives as tyrosine kinase inhibitors with antitumoral activity in vitro and in vivo in papillary dedifferentiated thyroid cancerAlessandro Antonelli, Guido Bocci, Concettina La Motta, et al.
Oncology Reports|July 5, 2016
EGFR and KRAS mutational analysis in a large series of Italian non-small cell lung cancer patients: 2,387 cases from a single centerRiccardo Giannini, Cristiana Lupi, Elisa Sensi, et al.
The Journal of Clinical Endocrinology and Metabolism|January 27, 2012
CLM94, a novel cyclic amide with anti-VEGFR-2 and antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivoAlessandro Antonelli, Guido Bocci, Concettina La Motta, et al.
Cancers|November 17, 2020
Assessment of HER2 Protein Overexpression and Gene Amplification in Renal Collecting Duct Carcinoma: Therapeutic ImplicationManuela Costantini, Carla Azzurra Amoreo, Liborio Torregrossa, et al.
Pageof 10

Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
Oncology Reports|September 3, 2009
Epidermal growth factor receptor and K-RAS mutations in 411 lung adenocarcinoma: a population-based prospective studyLaura Boldrini, Greta Alì, Silvia Gisfredi, et al.
Endocrine|September 12, 2023
SARS-CoV-2 spread to endocrine organs is associated with obesity: an autopsy study of COVID-19 casesAnello Marcello Poma, Alessio Basolo, Greta Alì, et al.
Cancers|April 13, 2024
Early-Stage Non-Small Cell Lung Cancer: Prevalence of Actionable Alterations in a Monocentric Consecutive CohortRossella Bruno, Anello Marcello Poma, Martina Panozzi, et al.
Archives of Pathology & Laboratory Medicine|June 3, 2014
ALK rearrangement in a large series of consecutive non-small cell lung cancers: comparison between a new immunohistochemical approach and fluorescence in situ hybridization for the screening of patients eligible for crizotinib treatmentGreta Alì, Agnese Proietti, Serena Pelliccioni, et al.
European Journal of Radiology|August 20, 2024
Large cell carcinoma of the lung: LDCT features and survival in screen-detected casesMario Mascalchi, Donella Puliti, Edoardo Cavigli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2017
Homeobox B9 Mediates Resistance to Anti-VEGF Therapy in Colorectal Cancer PatientsCarmine Carbone, Geny Piro, Francesca Simionato, et al.
The Journal of Clinical Endocrinology and Metabolism|December 15, 2010
Novel pyrazolopyrimidine derivatives as tyrosine kinase inhibitors with antitumoral activity in vitro and in vivo in papillary dedifferentiated thyroid cancerAlessandro Antonelli, Guido Bocci, Concettina La Motta, et al.
Oncology Reports|July 5, 2016
EGFR and KRAS mutational analysis in a large series of Italian non-small cell lung cancer patients: 2,387 cases from a single centerRiccardo Giannini, Cristiana Lupi, Elisa Sensi, et al.
The Journal of Clinical Endocrinology and Metabolism|January 27, 2012
CLM94, a novel cyclic amide with anti-VEGFR-2 and antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivoAlessandro Antonelli, Guido Bocci, Concettina La Motta, et al.
Cancers|November 17, 2020
Assessment of HER2 Protein Overexpression and Gene Amplification in Renal Collecting Duct Carcinoma: Therapeutic ImplicationManuela Costantini, Carla Azzurra Amoreo, Liborio Torregrossa, et al.
Pageof 10